Abstract
MESA is an exciting, extremely expensive, labor intensive new technique that provides a new form of therapy for couples with previously untreatable conditions. MESA has supplanted the use of alloplastic spermatocele in patients with nonreconstructible epididymal obstruction. The clinical evolution of MESA has altered our understanding of epididymal and sperm physiology. This technology has also provided the scientific community with a unique ability to study the genetic inheritance of CF. However, it has also given us the ability to bypass natural selection processes. It is imperative that appropriate genetic counselling be provided to all candidates for MESA with CVA. Patients must be aware of the emotional and financial risks before embarking on this form of therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 255-260 |
| Number of pages | 6 |
| Journal | Assisted Reproduction Reviews |
| Volume | 3 |
| Issue number | 4 |
| State | Published - 1993 |
| Externally published | Yes |